Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy in Biliary Atresia
NCT05925309Recruiting
- Sponsor
- Children's Hospital of Fudan University
- Start
- Jul 2023
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of sulfamethoxazole and cefaclor in cholangitis (2 arms), sponsored by Children's Hospital of Fudan University. Primary endpoint: The occurrence of cholangitis (confirmed or suspected) within 6 months after KP. Started Jul 2023; status: recruiting.
02
Drugs
sulfamethoxazolecefaclor
03
Conditions
cholangitis
Beyond the preview
Go deeper on NCT05925309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05925309.